English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA team led by Florida State University chemists has developed a new test for detecting biological markers related to several types of cancer. Their research was recently published in Journal of the American Chemical Society.
Tag: Breast Cancer
Does depression affect the care and survival of patients with breast cancer?
In a recent study, having depression before or after a breast cancer diagnosis was associated with a lower likelihood of survival. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
AACR 2023: Ohio State experts share new findings on immuno-oncology, ‘smart-drugs,’ obesity-related endometrial cancers and other research topics
New smart-drug treatment options for pancreatic cancer, immuno-oncology treatments and real-time immune-monitoring strategies are among the research topics to be presented by investigators at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) at the American Association for Cancer Research (AACR) annual meeting held April 14-19 at the Orange County Convention Center in Orlando, Florida.
Living Beyond Breast Cancer to Host 17th Annual Thriving Together Conference on Metastatic Breast Cancer April 28–30, 2023 in Philadelphia
Living Beyond Breast Cancer’s Thriving Together 2023 Conference on Metastatic Breast Cancer, the nation’s premier and longest-running conference for people affected by stage IV breast cancer, will be held April 28–30, 2023 at the Hilton Philadelphia at Penn’s Landing as well as virtually.
MD Anderson Research Highlights for March 8, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Nutrition specialist: Low-carb diets can improve treatment of liver metastases in breast cancer patients
University of Illinois researchers have found that liver metastases in breast cancer patients rely on increased amounts of glucose, indicating the possibility of a dietary intervention to reduce tumor burden and increase treatment efficacy. Approximately one-third of breast cancer patients…
Cancer stage and receptor status indicate a breast cancer survivor’s risk of recurrence
New research indicates that for patients with breast cancer, the cancer’s stage and receptor status can help clinicians predict whether and when cancer might recur after initial treatment.
Risk of cancer remains high for women over 50 with genetic BRCA1 or BRCA2 mutation
Although genetic mutations in BRCA1 or BRCA2 are associated with a younger onset of breast and ovarian cancer, women with these genetic mutations continue to face a high risk of cancer incidence after age 50, even if they have not been previously diagnosed with cancer.
Introduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of Kansans
Susan G. Komen®, the world’s leading breast cancer organization, applauds Senator Dinah Sykes (D-Lenexa) and the House Committee on Health and Human Services for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy.
Breast cancer disparity equally impacted by social determinants of health, tumor biology
Researchers calculated the effect of social determinants of health — specifically neighborhood disadvantage and insurance status — on mortality and found they accounted for 19% of the disparity. They also calculated the effect of biological characteristics of the tumors by looking at data from genomic laboratory test results, which were used to anticipate tumor response to chemotherapy and likelihood of recurrence. They found tumor biology accounted for 20% of the disparity.
Introduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of Arizonans
Legislation introduced in Arizona would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 6,240 people will be diagnosed with breast cancer and more than 920 will die of the disease in Arizona alone.
Cleveland Clinic Announces Next Step in Preventive Breast Cancer Vaccine Study
Cleveland Clinic researchers have launched the next step in their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
Introduction of Diagnostic and Supplemental Imaging Legislation Would Benefit Thousands of Marylanders
Susan G. Komen®, the world’s leading breast cancer organization, applauds Senator Pamela Beidle (D-Anne Arundel) and Delegate Sheree Sample-Hughes (D-Dorchester) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 5,760 people will be diagnosed with breast cancer and more than 850 will die of the disease in Maryland alone.
Legislation Introduced In Oklahoma Would Increase Access to Treatments for Metastatic Cancer Patients
Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Nicole Miller (R-Edmond) for working with Komen to introduce legislation that would prohibit step therapy requirements for metastatic cancer patients. Komen believes patients and their physicians should be able to make treatment decisions based on the particular needs of each patient without the burden of harmful insurer policies.
Medicaid Expansion in Southern States Associated with Earlier and More Comprehensive Breast Cancer Treatment
Patients in Southern states that expanded Medicaid were less likely to be uninsured and diagnosed with stage IV cancer.
MD Anderson Research Highlights for February 1, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Using CRISPR to detect cancer biomarkers
Only a few forms of cancer can currently be diagnosed using blood samples. Now, researchers reporting in ACS Sensors have developed an easy-to-use method that can detect small amounts of cancer-related molecules in exosomes in plasma and effectively distinguish between malignant and benign samples.
Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs 69
Age-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new analysis of more than 500,000 patient records. Patients aged 70 were nearly twice as likely to be passed over for standard-of-care radiation as those aged 69. There were no similar gaps between other age pairs. The study is among the first to demonstrate an age cutoff heuristic in oncology.
Susan G. Komen® Applauds House Introduction of Bipartisan Metastatic Breast Cancer Access to Care Act
Bipartisan legislation introduced in the U.S. House of Representatives would make financial benefits and health insurance immediately available to people with terminal breast cancer.
The Medical Minute: Could that breast pain be cancer? When to get a mammogram
Pain in your breast means you better get a mammogram, right? Not always, says a Penn State Health radiologist, who sounds off on when it’s best to get your screening in this week’s Medical Minute.
Expert Available for Comment on Black Women, Breast Cancer and Clinical Trials
While there has been an overall decline in breast cancer deaths over the last 30 years, there is a persistent and significant mortality gap between Black women and white women. Black women are also disproportionately affected by more aggressive subtypes of…
Breast Cancer Risk Calculator Can Assess Risk of Advanced Breast Cancer
Breast cancer is now the leading cause of global cancer incidence among women but determining who will develop breast cancer is still a challenge for the medical community. A new tool, developed by researchers from UCSF and several other medical institutions, helps to calculate risk for those who may develop advanced breast cancer that goes undiagnosed despite regular screenings.
Introduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of Virginians
Legislation introduced in Virginia would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 7,810 people will be diagnosed with breast cancer and more than 1,150 will die of the disease.
Mayo Clinic researchers identify women with twice the risk of cancer in both breasts
Women with cancer in one breast may be at higher risk of developing cancer in the opposite breast if they are carriers of specific genetic changes that predispose them to develop breast cancer, according to a study led by the Mayo Clinic Comprehensive Cancer Center. The findings, published in the Journal of Clinical Oncology, will help personalize approaches to breast cancer screening and risk factors, study authors say.
New molecular blocker halts breast cancer metastasis
Cancer cells use feet-like protrusions called invadopodia to degrade underlying tissue, enter the bloodstream and form metastases in other organs.
Introduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of New Mexicans
Legislation introduced in New Mexico would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. Last year alone, more than 1,700 individuals were diagnosed with breast cancer and more than 290 died of the disease in New Mexico.
MD Anderson Research Highlights for January 11, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.
Mount Sinai’s Dubin Breast Cancer Center Raises $3 Million for 12th Anniversary
The Dubin Breast Center of The Tisch Cancer Institute at the Mount Sinai Health System celebrated its 12th anniversary with its annual gala on Monday, December 12.
Genetic profiling may identify patients with breast cancer who can safely omit radiation therapy after breast-conserving surgery
Patients with invasive breast cancer who had low scores on an investigational gene molecular signature had similar rates of local recurrence whether or not they received adjuvant radiation therapy after breast-conserving surgery.
Clues Found Regarding Tumor Suppressor Gene’s Breast Cancer Activity
Researchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to suppress formation of breast cancers.
MD Anderson Research Highlights: SABCS 2022 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into basic, translational and clinical cancer research from MD Anderson experts. This special edition features breast cancer presentations at the 2022 San Antonio Breast Cancer Symposium (SABCS) focused on the combination of everolimus and hormone therapy, a new driver for brain metastases in inflammatory breast cancer, improving treatment for men with breast cancer, and a new understanding of the importance of HER2 expression for patients with early-stage triple-negative breast cancers.
Women with Elevated Breast Cancer Risk Could See Mortality Benefit from Estrogen-Blocking Drugs
While it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce risk of developing new breast cancers, a new computer modeling study led by researchers at Georgetown Lombardi Comprehensive Cancer Center and colleagues showed that these treatments could also reduce the risk of dying from the disease in women who are at high risk.
Study in mice suggests that expression of estrogen-related gene can impact post-menopausal breast cancer risk and prevention strategies
In a study using a first-of-its kind mouse model of aging that mimics breast cancer development in estrogen receptor-positive post-menopausal women, investigators at Georgetown Lombardi Comprehensive Cancer Center and colleagues have determined that over-expression, or switching on of the Esr1 gene, could lead to elevated risk of developing estrogen receptor-positive breast cancer in older women.
Experts boost activity of potential therapeutic target in triple-negative breast cancer
Less than 20% of diagnosed breast cancers are designated “triple-negative,” lacking three types of receptors often found in other breast cancer types.
MD Anderson Research Highlights for November 30, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.
New study offers insight into the development of human triple negative breast cancers
Basal-like breast cancers, also known as triple-negative cancers, are an aggressive breast cancer subtype with poor treatment options.
When used as a biomarker, microRNA can help predict which breast cancer patients are more likely to see their cancer come back
MicroRNA (miRNA) can be used as a biomarker to predict which patients are likely to face breast cancer recurrence and mortality, according to study results published online ahead of print in the Journal of the American College of Surgeons (JACS).
Breast Cancer Survivorship Doubles
It was the information she couldn’t find that led Amy Kirkham, an assistant professor in the University of Toronto’s Faculty of Kinesiology & Physical Education (KPE), to her latest discovery.
Researchers Identify a Regulator of Breast Cancer Development
UT Southwestern researchers have identified a causative signaling pathway in breast cancer, providing potential new targets for treatment of the most common type of cancer in women.
Breast Cancer Survivor Uses Personal and Professional Experience to Help Others
Rensselaer Polytechnic Institute Professor of Computer Science, Cognitive Science, and Industrial and Systems Engineering Deborah McGuinness was diagnosed with breast cancer nearly 10 years ago. Her treatments were emotionally and physically challenging: McGuinness endured six months of chemotherapy, 33 radiation treatments, and four surgeries before emerging with current “no evidence of disease” status.
Breast Cancer Research Foundation Renews Support for Mount Sinai Research on Triple-Negative Breast Cancer
The Breast Cancer Research Foundation (BCRF) has renewed its funding to Elisa Port, MD, and Hanna Irie, MD, PhD, to study new therapeutic approaches that target aggressive triple-negative breast cancer. The latest installment of $225,000 brings the total to almost $2 million over the past nine years. It will fund research into the immune microenvironment of triple-negative breast cancer in order to identify new strategies to enhance cancer-fighting immune responses for this aggressive breast cancer, which traditionally has few options for treatment.
Spreading hope through humor — Markey Cancer patient, comedian shares her story
As a stand-up comedian, Debra Faulk is an expert at transforming the most difficult and uncomfortable moments of her life into something that lifts others. Active in the local comedy scene, the 54-year-old Lexington native uses standup as a platform to shine a light on serious health issues, with much of her routine inspired by her family’s experiences: one sister dealt with intellectual disabilities while another had breast cancer, her brother served in Desert Storm and came back with PTSD, her father had dementia, and her mother was on dialysis.
CANCER RESEARCH INSTITUTE TO HOST ANNUAL VIRTUAL IMMUNOTHERAPY PATIENT SUMMIT ON NOVEMBER 11-12, 2022
Free online event for cancer patients and caregivers featuring immunotherapy experts and patient advocates taking place Nov. 11-12, 2022.
Study finds earlier mammograms for women with family history of breast cancer may not be needed
A new study may prompt medical experts to rethink when to start mammograms for women who have a mother, sister or daughter diagnosed with breast cancer.
The Medical Minute: What happens at a 3-D mammogram
It’s not your mom’s mammogram. Take a look inside a 3-D exam room in this week’s Medical Minute.
MD Anderson Research Highlights for October 19, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. Current advances include a combination approach to overcome PARP inhibitor resistance in breast and ovarian cancers, a deeper understanding of STAT3 mutations as drivers of disease progression, insights into the “obesity paradox” in men with advanced melanoma, a prognostic model for rapidly progressing vestibular schwannoma, and a role for cellular trafficking proteins in creating a metastasis-promoting lung cancer microenvironment.
Breast Cancer Awareness Month showcases positives of informational marketing
As Breast Cancer Awareness month takes its stride, companies pushing initiatives on the topic are utilizing informational marketing techniques that not only raise awareness but could also build customer loyalty, according to a Virginia Tech expert. “A lot of people…
New Study Shines Light on Financial Resources for Women with Breast Cancer
A new study published in Clinical Breast Cancer shines a light on the significant financial burden associated with breast cancer treatment. The study, “Mitigating Financial Toxicity in Breast Cancer from Diagnosis to Treatment and Reconstruction,” was co-authored by Nikita Roy…
FSU faculty available to speak for Breast Cancer Awareness Month
By: Bill Wellock | Published: October 10, 2022 | 1:11 pm | SHARE: More than 264,000 people are diagnosed with breast cancer every year in the United States. Although deaths from breast cancer have declined over time, it remains the second-leading cause of cancer death among women.October is Breast Cancer Awareness Month, an opportunity to focus on the impact of this disease.
Tiah Tomlin-Harris: For Black Women with Breast Cancer, Knowledge is Power
When she was diagnosed in 2015 with triple-negative breast cancer in her 30s, Tiah Tomlin-Harris of Atlanta discovered there was a lot she didn’t know about the disease. By discovering Living Beyond Breast Cancer’s (LBBC) Young Advocate program and becoming…